Publications

A call to action for the new decade of vaccines.

Moxon, ER; Das, P; GREENWOOD, B; HEYMANN, DL; Horton, R; Levine, OS; Plotkin, S; Nossal, G;

2011

Lancet, (2011).378 9788 10.1016/S0140-6736(11)60766-6.

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

FLASCHE, S; VAN HOEK, AJ; Sheasby, E; Waight, P; Andrews, N; Sheppard, C; George, R; MILLER, E;

2011

PLoS medicine, (2011).8 4 10.1371/journal.pmed.1001017.

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.

Urueña, A; Pippo, T; Betelu, MS; Virgilio, F; Giglio, N; Gentile, A; Jimenez, SG; Jáuregui, B; CLARK, AD; Diosque, M; Vizzotti, C;

2011

Vaccine, (2011).29 31 10.1016/j.vaccine.2011.04.111.

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

Gilson, R; Nugent, D; Bennett, K; Doré, CJ; Murray, ML; Meadows, J; Haddow, LJ; Lacey, C; SANDMANN, F; JIT, M; Soldan, K; Tetlow, M; Caverly, E; Nathan, M; Copas, AJ;

2011

HEALTH TECHNOLOGY ASSESSMENT, (2011).24 47 10.3310/hta24470.

Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.

Barreto, ML; Pereira, SM; PILGER, D; Cruz, AA; Cunha, SS; Sant'Anna, C; Ichihara, MY; Genser, B; RODRIGUES, LC;

2011

Vaccine, (2011).29 31 10.1016/j.vaccine.2011.05.023.

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

Olotu, A; Lusingu, J; Leach, A; Lievens, M; Vekemans, J; Msham, S; Lang, T; Gould, J; Dubois, M-C; Jongert, E; Vansadia, P; Carter, T; Njuguna, P; Awuondo, KO; Malabeja, A; Abdul, O; Gesase, S; Mturi, N; DRAKELEY, CJ; Savarese, B; Villafana, T; Lapierre, D; Ballou, WR; Cohen, J; Lemnge, MM; ... Bejon, P.

2011

LANCET INFECTIOUS DISEASES, (2011).11 2 10.1016/S1473-3099(10)70262-0.

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Postma, MJ; JIT, M; Rozenbaum, MH; Standaert, B; Tu, H-A; Hutubessy, RC W;

2011

BMC medicine, (2011).9 1 10.1186/1741-7015-9-84.

Immunological correlates of protection for the RTS,S candidate malaria vaccine.

GREENWOOD, B;

2011

The Lancet infectious diseases, (2011).11 2 10.1016/S1473-3099(11)70001-9.

Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.

Fowlkes, A; Witte, D; Beeler, J; Audet, S; Garcia, P; Curns, A; Yang, C; Fudzulani, R; Broadhead, R; Bellini, WJ; CUTTS, F; Helfand, RF;